Showing results (151-160 of 5,338) with videos related to
Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|March 29, 2022
High expression of HHLA2 predicts poor prognosis in medullary thyroid carcinomaYongzhi Niu, Wei Wang, Xiaodan Jiang, et al.Japanese Journal of Clinical Oncology|March 29, 2022
Molecular classification of patients with NMIBC predicts the efficacy of intravesical chemotherapy with pirarubicin, pharmorubicin and gemcitabine-immunohistochemistry-based classificationTianwei Wang, Xiaobing Niu, Bing ZhongJapanese Journal of Clinical Oncology|March 12, 1999
Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary reportK Shimozuma, H Sonoo, M Fukunaga, et al.Japanese Journal of Clinical Oncology|March 25, 1999
The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. The Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology SectionH Tsuda, F Akiyama, M Kurosumi, et al.Japanese Journal of Clinical Oncology|March 25, 1999
Number and anatomical extent of lymph node metastases in gastric cancer: analysis using intra-lymph node injection of activated carbon particles (CH40)K Okamoto, K Sawai, H Minato, et al.Japanese Journal of Clinical Oncology|March 25, 1999
Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Center, Japan, 1962-1996S Kaneko, N YamaguchiJapanese Journal of Clinical Oncology|November 4, 2000
The clinical utility of measuring total PSA, PSA density, gamma-seminoprotein and gamma-seminoprotein/total PSA in prostate cancer predictionR Sasaki, T Habuchi, K Sato, et al.Japanese Journal of Clinical Oncology|November 4, 2000
Hemangioma of the rib: a case reportT Okumura, H Asamura, H Kondo, et al.Japanese Journal of Clinical Oncology|January 13, 2001
Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomasP E Carvalho, L Antonãngelo, F D Bernardi, et al.Japanese Journal of Clinical Oncology|January 13, 2001
Phase II study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancerS C Chen, M C Lin, J W Chang, et al.Pageof 534